Bank of America’s Biotech Acquisition Company Warrant BIOTW Stock Holding History

Bank of America’s Portfolio BIOTW Stock Details BIOTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,063	Closed	-$634	–	8623
2022 Q4	$634	Hold	10,063	–	–	﹤0.01%	7404
2022 Q3	$1K	Hold	10,063	–	–	﹤0.01%	7741
2022 Q2	$1K	Hold	10,063	–	–	﹤0.01%	7928
2022 Q1	$2K	Hold	10,063	–	–	﹤0.01%	8069
2021 Q4	$7K	Hold	10,063	–	–	﹤0.01%	7781
2021 Q3	$7K	Hold	10,063	–	–	﹤0.01%	7670
2021 Q2	$9K	Sell	10,063 -60,008	-86%	-$41.7K	﹤0.01%	7335
2021 Q1	$42K	Buy	+70,071	New	+$49.4K	﹤0.01%	6701

Bank of America's BIOTW Position: Q1 2023 in Review

Bank of America sold out of Biotech Acquisition Company Warrant (BIOTW) in Q1 2023, closing a stake of 10,063 shares — an estimated $634 sold.

Bank of America first reported a position in BIOTW in Q1 2021 and held it in 8 quarters. The position peaked at $42K in Q1 2021. 0 funds tracked by Wall St. Rank hold BIOTW as of Q1 2023.

Bank of America reported no remaining Biotech Acquisition Company Warrant position as of Q1 2023 after selling out during the quarter.
Bank of America sold 10,063 Biotech Acquisition Company Warrant shares in Q1 2023, an estimated $634.
Bank of America first reported a position in Biotech Acquisition Company Warrant in Q1 2021 and held it in 8 quarters.
Bank of America's Biotech Acquisition Company Warrant position peaked at $42K in Q1 2021.
0 funds tracked by Wall St. Rank held Biotech Acquisition Company Warrant as of Q1 2023.

Based on Bank of America's 13F filing for Q1 2023, filed 12 May 2023.